<!DOCTYPE html>
<html lang="cs">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ONWARD Medical zaznamenÃ¡vÃ¡ silnÃ½ prodej ARC-EX v USA a dosahuje vÃ½znamnÃ© vÄ›deckÃ© i regulaÄnÃ­ milnÃ­ky ve tÅ™etÃ­m ÄtvrtletÃ­ 2025 | Marigold.cz Tech News</title>
    <meta name="description" content="NizozemskÃ¡ spoleÄnost ONWARD Medical, specializujÃ­cÃ­ se na neurotechnologie pro obnovu pohybu u lidÃ­ se spinÃ¡lnÃ­mi poranÄ›nÃ­mi, oznÃ¡mila vÃ½znamnÃ½ komerÄnÃ­ rÅ¯st, ">
    <link rel="canonical" href="https://www.marigold.cz/tech-news/2025-11-24/onward-medical-drives-strong-us-arc-ex-adoption-an/">
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; line-height: 1.6; color: #374151; background: #f3f4f6; }
        .container { max-width: 800px; margin: 0 auto; padding: 2rem; }
        .tech-news-article { background: white; border-radius: 12px; box-shadow: 0 4px 6px rgba(0,0,0,0.1); padding: 2rem; margin: 2rem 0; }
        .source-info { display: flex; align-items: center; gap: 0.75rem; margin-bottom: 1rem; flex-wrap: wrap; }
        .source-emoji { font-size: 1.5rem; }
        .source-name { font-weight: 600; color: #374151; }
        .importance-indicator { display: flex; gap: 2px; margin-left: auto; }
        .star { color: #fbbf24; font-size: 1.2rem; }
        .star.empty { color: #d1d5db; }
        .article-title { font-size: 2rem; font-weight: 700; line-height: 1.2; margin-bottom: 1rem; color: #111827; }
        .article-meta { display: flex; align-items: center; gap: 1rem; font-size: 0.875rem; color: #6b7280; margin-bottom: 1.5rem; }
        .category { padding: 0.25rem 0.75rem; border-radius: 1rem; font-weight: 500; font-size: 0.75rem; text-transform: uppercase; background: #e5e7eb; color: #374151; }
        .article-image { margin: 1.5rem 0; border-radius: 8px; overflow: hidden; }
        .article-image img { width: 100%; height: auto; display: block; }
        .article-content { font-size: 1.125rem; line-height: 1.7; margin-bottom: 2rem; }
        .article-content h2 { font-size: 1.5rem; margin: 1.5rem 0 1rem; color: #111827; }
        .article-content p { margin-bottom: 1rem; }
        .article-footer { border-top: 1px solid #e5e7eb; padding-top: 1.5rem; }
        .read-more-btn { display: inline-flex; align-items: center; gap: 0.5rem; padding: 0.75rem 1.5rem; background: #3b82f6; color: white; text-decoration: none; border-radius: 8px; font-weight: 500; }
        .read-more-btn:hover { background: #2563eb; }
        .original-title { margin-top: 1rem; color: #6b7280; font-size: 0.875rem; }
        .back-link { display: inline-block; margin-bottom: 1rem; color: #3b82f6; text-decoration: none; }
        .back-link:hover { text-decoration: underline; }
        .archive-notice { background: #fef3c7; border: 1px solid #f59e0b; border-radius: 8px; padding: 1rem; margin-bottom: 1rem; font-size: 0.875rem; color: #92400e; }
        @media (max-width: 640px) {
            .container { padding: 1rem; }
            .tech-news-article { padding: 1.5rem; margin: 1rem 0; }
            .article-title { font-size: 1.5rem; }
            .source-info { flex-direction: column; align-items: flex-start; }
            .importance-indicator { margin-left: 0; margin-top: 0.5rem; }
        }
    </style>
</head>
<body>
    <div class="container">
        <a href="/tech-news/" class="back-link">&larr; ZpÄ›t na Tech News</a>

        <div class="archive-notice">
            Tento ÄlÃ¡nek je z archivu. Byl publikovÃ¡n 24.11.2025.
        </div>

        <article class="tech-news-article">
            <header>
                <div class="source-info">
                    <span class="source-emoji">ğŸ“°</span>
                    <span class="source-name">GlobeNewswire</span>
                    <div class="importance-indicator">
                        <span class="star">â˜…</span><span class="star">â˜…</span><span class="star">â˜…</span><span class="star">â˜…</span><span class="star empty">â˜†</span>
                    </div>
                </div>

                <h1 class="article-title">ONWARD Medical zaznamenÃ¡vÃ¡ silnÃ½ prodej ARC-EX v USA a dosahuje vÃ½znamnÃ© vÄ›deckÃ© i regulaÄnÃ­ milnÃ­ky ve tÅ™etÃ­m ÄtvrtletÃ­ 2025</h1>

                <div class="article-meta">
                    <time datetime="2025-11-24T06:30:00+00:00">24.11.2025</time>
                    <span class="category">neurotechnologie</span>
                </div>
            </header>

            
            <div class="article-image">
                <img src="https://ml.globenewswire.com/Resource/Download/a60261ec-0c66-4acb-8726-e567073990a2" alt="ONWARD Medical zaznamenÃ¡vÃ¡ silnÃ½ prodej ARC-EX v USA a dosahuje vÃ½znamnÃ© vÄ›deckÃ© i regulaÄnÃ­ milnÃ­ky ve tÅ™etÃ­m ÄtvrtletÃ­ 2025" loading="lazy">
            </div>
        

            <div class="article-content">
                <h2>Souhrn</h2>
<p>SpoleÄnost ONWARD Medical ve tÅ™etÃ­m ÄtvrtletÃ­ 2025 dosÃ¡hla vÃ½znamnÃ½ch komerÄnÃ­ch, regulaÄnÃ­ch i vÄ›deckÃ½ch ÃºspÄ›chÅ¯: prodala 40 jednotek svÃ©ho neinvazivnÃ­ho systÃ©mu ARC-EX v USA, zÃ­skala schvÃ¡lenÃ­ FDA pro jeho domÃ¡cÃ­ pouÅ¾itÃ­ a zÃ¡roveÅˆ zÃ­skala povolenÃ­ k zahÃ¡jenÃ­ globÃ¡lnÃ­ klinickÃ© studie Empower BP s implantovatelnÃ½m systÃ©mem ARC-IM. SouÄasnÄ› zÃ­skala CE znaÄku pro ARC-EX a publikovala vÃ½sledky ve vÃ½znamnÃ½ch vÄ›deckÃ½ch Äasopisech.</p>
<h2>KlÃ­ÄovÃ© body</h2>
<ul>
<li>Prodej 40 systÃ©mÅ¯ ARC-EX v USA bÄ›hem Q3 2025</li>
<li>FDA schvÃ¡lila domÃ¡cÃ­ pouÅ¾itÃ­ ARC-EX v USA</li>
<li>FDA udÄ›lila IDE (Investigational Device Exemption) pro ARC-IM, coÅ¾ umoÅ¾Åˆuje zahÃ¡jenÃ­ studie Empower BP</li>
<li>CE znaÄka pro ARC-EX v EvropÄ›</li>
<li>Publikace klinickÃ½ch vÃ½sledkÅ¯ v prestiÅ¾nÃ­ch Äasopisech Nature, Nature Medicine a Neurology: Clinical Practice</li>
</ul>
<h2>Podrobnosti</h2>
<p>ONWARD Medical je nizozemskÃ¡ neurotechnologickÃ¡ spoleÄnost zamÄ›Å™enÃ¡ na terapie obnovujÃ­cÃ­ pohyb a nezÃ¡vislost u lidÃ­ se spinÃ¡lnÃ­mi poranÄ›nÃ­mi (SCI). JejÃ­ neinvazivnÃ­ systÃ©m ARC-EX vyuÅ¾Ã­vÃ¡ transkutÃ¡nnÃ­ elektrickou stimulaci mÃ­chy (tSCS) k aktivaci nervovÃ½ch drah pod poranÄ›nÃ­m. SchvÃ¡lenÃ­ FDA pro domÃ¡cÃ­ pouÅ¾itÃ­ ARC-EX vÃ½raznÄ› rozÅ¡iÅ™uje trÅ¾nÃ­ potenciÃ¡l, protoÅ¾e pacienti jiÅ¾ nejsou omezeni na klinickÃ¡ centra. Tento krok podporuje Å¡irÅ¡Ã­ dostupnost terapie a sniÅ¾uje bariÃ©ry pro dlouhodobÃ© pouÅ¾Ã­vÃ¡nÃ­.</p>
<p>ZÃ¡roveÅˆ spoleÄnost pokroÄila s implantovatelnÃ½m systÃ©mem ARC-IM, kterÃ½ umoÅ¾Åˆuje pÅ™esnÄ›jÅ¡Ã­ a trvalejÅ¡Ã­ neuromodulaci. FDA schvÃ¡lila IDE pro globÃ¡lnÃ­ pivotal studii Empower BP, kterÃ¡ bude hodnotit ÃºÄinnost ARC-IM u pacientÅ¯ s chronickou hypotenzÃ­ po spinÃ¡lnÃ­m poranÄ›nÃ­ â€“ Äastou a zÃ¡vaÅ¾nou komplikacÃ­. CE znaÄka pro ARC-EX dÃ¡le posiluje evropskou pÅ™Ã­tomnost spoleÄnosti.</p>
<p>VÄ›deckÃ¡ komunita podporuje technologie ONWARD Å™adou publikacÃ­ v prestiÅ¾nÃ­ch Äasopisech, coÅ¾ posiluje dÅ¯vÄ›ru v klinickou validitu pÅ™Ã­stupu. FinanÄnÄ› spoleÄnost zÃ­skala v Å™Ã­jnu pÅ™es 50 milionÅ¯ eur, coÅ¾ jÃ­ zajiÅ¡Å¥uje provoz aÅ¾ do prvnÃ­ho ÄtvrtletÃ­ 2027.</p>
<h2>ProÄ je to dÅ¯leÅ¾itÃ©</h2>
<p>Tento pokrok ukazuje, Å¾e neurotechnologie pro obnovu funkce po spinÃ¡lnÃ­m poranÄ›nÃ­ pÅ™echÃ¡zÃ­ ze stÃ¡dia experimentÃ¡lnÃ­ho vÃ½zkumu do klinickÃ© a komerÄnÃ­ reality. SchvÃ¡lenÃ­ pro domÃ¡cÃ­ pouÅ¾itÃ­ je klÃ­ÄovÃ½m krokem k masovÃ© dostupnosti, zatÃ­mco studie s implantovatelnÃ½m systÃ©mem ARC-IM otevÃ­rÃ¡ cestu k Å™eÅ¡enÃ­ i jinÃ½ch neurologickÃ½ch poruch, jako je dysautonomie. V kontextu Å¡irÅ¡Ã­ho neurotechnologickÃ©ho pole â€“ vÄetnÄ› BCI (brain-computer interface) â€“ pÅ™edstavuje ONWARD pragmatickÃ½ a regulacÃ­ ovÄ›Å™enÃ½ pÅ™Ã­stup, kterÃ½ mÅ¯Å¾e slouÅ¾it jako model pro dalÅ¡Ã­ terapeutickÃ© platformy.</p>
<hr />
<p><a href="https://www.globenewswire.com/news-release/2025/11/24/3193193/0/en/ONWARD-Medical-Drives-Strong-US-ARC-EX-Adoption-and-Achieves-Important-Scientific-and-Regulatory-Milestones-in-Q3-2025.html">ÄŒÃ­st pÅ¯vodnÃ­ ÄlÃ¡nek</a></p>
<p><strong>Zdroj:</strong> ğŸ“° GlobeNewswire</p>
            </div>

            <footer class="article-footer">
                <a href="https://www.globenewswire.com/news-release/2025/11/24/3193193/0/en/ONWARD-Medical-Drives-Strong-US-ARC-EX-Adoption-and-Achieves-Important-Scientific-and-Regulatory-Milestones-in-Q3-2025.html" target="_blank" rel="noopener" class="read-more-btn">
                    ÄŒÃ­st pÅ¯vodnÃ­ ÄlÃ¡nek &rarr;
                </a>

                <div class="original-title"><small>PÅ¯vodnÃ­ nÃ¡zev: ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025</small></div>
            </footer>
        </article>

        <p style="text-align: center; color: #6b7280; font-size: 0.875rem; margin-top: 2rem;">
            &copy; 2025 <a href="https://www.marigold.cz" style="color: #3b82f6;">Marigold.cz</a>
        </p>
    </div>
</body>
</html>
